Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00309166
What this trial is testing

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males.

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 270
Testing effectiveness (Phase 2)Study completedNCT03682120
What this trial is testing

Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 372
Testing effectiveness (Phase 2)Study completedNCT05576623
What this trial is testing

Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine

Who this might be right for
COVID-19Vaccines
Cellid Co., Ltd. 320
Early research (Phase 1)Study completedNCT01351948
What this trial is testing

Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909

Who this might be right for
Malaria
University of Oxford 35
Testing effectiveness (Phase 2)Study completedNCT00742885
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine

Who this might be right for
Influenza
GlaxoSmithKline 100
Testing effectiveness (Phase 2)Study completedNCT00980850
What this trial is testing

Swine Flu (Novel Influenza A H1N1) Vaccine Study

Who this might be right for
Influenza
University of Oxford 1,000
Post-approval studies (Phase 4)Study completedNCT06389513
What this trial is testing

Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants

Who this might be right for
Epidemic Meningitis
CanSino Biologics Inc. 3,011
Testing effectiveness (Phase 2)Study completedNCT02347423
What this trial is testing

3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants

Who this might be right for
Poliomyelitis
Statens Serum Institut 824
Post-approval studies (Phase 4)Study completedNCT00169858
What this trial is testing

Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections

Who this might be right for
Hepatitis BVaccination
Laval University 1,129
Post-approval studies (Phase 4)Study completedNCT05080218
What this trial is testing

COVID-19 VaccinE Response in Rheumatology Patients

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisSpondylarthritis
Jeffrey Curtis 841
Large-scale testing (Phase 3)Study completedNCT03699124
What this trial is testing

Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial

Who this might be right for
Smallpox
Bavarian Nordic 1,129
Testing effectiveness (Phase 2)Looking for participantsNCT06932523
What this trial is testing

Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals

Who this might be right for
Herpes Zoster (HZ)
Shanghai Institute Of Biological Products 645
Testing effectiveness (Phase 2)Study completedNCT03698279
What this trial is testing

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 665
Testing effectiveness (Phase 2)Study completedNCT05205096
What this trial is testing

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 480
Testing effectiveness (Phase 2)Study completedNCT01326546
What this trial is testing

Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Chongqing Jiachen Biotechnology Ltd. 378
Large-scale testing (Phase 3)Study completedNCT03526978
What this trial is testing

An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old Infants

Who this might be right for
Poliomyelitis
Sinovac Biotech Co., Ltd 1,200
Testing effectiveness (Phase 2)WithdrawnNCT00614640
What this trial is testing

Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Ended earlyNCT00095576
What this trial is testing

Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)

Who this might be right for
AIDSHIV Infections
Merck Sharp & Dohme LLC 3,000
Not applicableStudy completedNCT01408290
What this trial is testing

Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 256
Post-approval studies (Phase 4)UnknownNCT04636827
What this trial is testing

Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA

Who this might be right for
Vaccination
China National Biotec Group Company Limited 600
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation